Detection Of MYD88 L265P In Peripheral Blood Of Patients With Waldenström's Macroglobulinemia and IgM Monoclonal Gammopathy Of Undetermined Significance
Lian Xu(Huazhong Agricultural University), Steven P. Treon(Dana-Farber Cancer Institute), Robert Manning(Dana-Farber Cancer Institute), Yang Cao(Nanjing Tech University), Sandra Kanan(University of Washington Medical Center), Zachary R. Hunter(Harvard University), Neil Lindeman(Brigham and Women's Hospital), Jiaji G. Chen(Boston Medical Center), Xia Liu(Dana-Farber Cancer Institute), Guang Yang(Dana-Farber Cancer Institute), Yangsheng Zhou(Dana-Farber Cancer Institute), Christopher J. Patterson(Dana-Farber Cancer Institute), Christina Tripsas(Dana-Farber Cancer Institute)
Cited by 3
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905
Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis
|Experimental & Molecular Medicine|2022|321
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|282